Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price lowered by Scotiabank from $105.00 to $80.00 in a ...
Scotiabank reduced their FY2025 earnings estimates for shares of Freeport-McMoRan in a note issued to investors on Wednesday, ...
Tumbling stock markets and signs of tightening credit may make the Federal Reserve's job even more difficult this week as US ...
There are headwinds whether you choose individual stocks or the S&P 500, including President Donald Trump’s tariff policies ...
With stocks struggling out of the gate in 2025, a wide range of Wall Street forecasts, both positive and negative, feel like ...
Speculative traders in the $7.5-trillion-a-day currency market turned bearish on the US dollar for the first time since ...
A lender has moved to sell an office tower in San Francisco’s Financial District after Kylli defaulted on a $350 million ...
An effort to carve off the commercial sites of Trader Joe’s grocery store and Chase Bank from the Hampshire Mall property ...
FedEx shares sank Friday as several analysts dropped their price targets for the shipping giant's stock after the company ...
Germany's upper house, the Bundesrat, Thursday voted 53-16 to approve a massive defense and infrastructure spending bill. The ...
Deutsche Bank Securities Inc., Mudrick Capital Management and other noteholders of Ambac Assurance Corp. sued the bond ...
We're debating over whether to put all of that cash into the S&P 500 or buy individual stocks. We have chosen two stocks that have done well over the past five years: Chevron, with a 22% annual return ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results